Neurogene (NGNE) Tax Provisions (2013 - 2014)
Neurogene (NGNE) posted Tax Provisions of $185222.0 for Q4 2014, up 83533.33% on a QoQ basis from -$222.0 in Q3 2014, and up 420859.09% year-over-year from N/an in Q4 2013.
Neurogene (NGNE) Tax Provisions (2013 - 2014) Analysis & Trends
Neurogene's Tax Provisions history runs 2 years deep, the most recent figure standing at $185222.0 for Q4 2014.
- Quarterly Tax Provisions rose 420859.09% year-over-year to $185222.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $180000.0 (changed N/A YoY) and the FY2015 annual result came in at $446000.0, up 141.08% from the prior year.
- Tax Provisions was $185222.0 for Q4 2014 at Neurogene, up from -$222.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $185222.0 in Q4 2014 and bottomed at -$5044.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Neurogene | 776.69 Mn | 776.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 185,222.00 |
| Sep 30, 2014 | -222.00 |
| Dec 31, 2013 | 44.00 |
| Sep 30, 2013 | -5,044.00 |